• By Real World Health Care Editorial Staff  |  Nov 1, 2022

    Removing Barriers to Hepatitis C Treatment

    In August, the Centers for Disease Control and Prevention (CDC) issued a sobering report: Only one in three people with health insurance receive timely treatment for their hepatitis C. The figure is even lower for people covered by Medicare: nearly three in four (72 percent) are not treated. What happens…more.

    Categories: Hepatitis C
  • By Real World Health Care Editorial Staff  |  Jul 23, 2021

    Hepatitis C: Fighting the Stigma as Well as the Disease

    Warren Hall has grown accustomed to the fear and trepidation in the voices of people who have been diagnosed with hepatitis C. As National Manager of Support Services for the American Liver Foundation (ALF), Hall regularly speaks with callers to the ALF helpline and participates in live chat sessions to…more.

    Categories: Hepatitis C
  • By Oriol R. Gutierrez Jr., Editor-in-Chief, Hep magazine  |  May 26, 2021

    The Importance of Being Tested for Hepatitis

    I remember the first time I was tested for hepatitis C virus (HCV). It was shortly after I tested HIV positive in 1992. I found out I was living with HIV the day after my 22nd birthday. After the initial shock, I soon started seeing an HIV specialist for my…more.

  • By Real World Health Care Editorial Staff  |  May 12, 2021

    May Is Hepatitis Awareness Month

    This month, Real World Health Care focuses on Hepatitis C, a viral disease that affects 2.4 million people in the U.S. and infects about 50,300 new people each year, according to the Centers for Disease Control and Prevention (CDC). For some, hepatitis C is a mild illness lasting a few…more.

    Categories: COVID 19, Hepatitis C
  • By Real World Health Care Editorial Staff  |  Sep 11, 2019

    Obesity and Fatty Liver Disease: The Link Between Metabolic Disorders and NASH

    For decades, the general public has been aware of the many health risks of being obese, including diabetes, heart disease and certain cancers. However, many are not be aware that obesity is also linked to liver disease: specifically Non-Alcoholic Fatty Liver Disease (NAFLD), which in its most severe form, becomes…more.

  • By Real World Health Care Editorial Staff  |  Jul 31, 2019

    Where Does NASH Stand on the Global Public Health Agenda?

    This week, Real World Health Care continues our series on Non-Alcoholic Steatohepatitis (NASH) by featuring an interview with Donna Cryer, JD, president and CEO of the Global Liver Institute (GLI). Cryer founded the GLI on the 20th anniversary of her liver transplant due to an autoimmune disease. Today, four years…more.

  • By Wayne Eskridge, President & CEO, Fatty Liver Foundation  |  Jul 3, 2019

    NASH: A Disease without Symptoms but Lots of Hope

    What if you had a liver disease but nobody told you until it was too late? Typically, nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are silent diseases. They have no symptoms. Even if cirrhosis has developed, there are often no symptoms until the liver has become so damaged…more.

  • By Linda Barlow  |  May 21, 2015

    Awareness and Assistance Are Crucial to Fighting Hepatitis C

    May is Hepatitis Awareness Month, a time when the healthcare and patient advocacy communities rally support for the millions of Americans afflicted with the disease, including an estimated 3.2 million suffering from chronic Hepatitis C (also known as HCV). Over time, chronic Hepatitis C can cause serious health problems, including…more.

  • By Linda Barlow  |  Jul 30, 2013

    Targeted Therapies Open Door to Improved Outcomes and Lower Costs to Treat HCV

    As we were reminded on World Hepatitis Day, early detection is critical to turning the tide of this “silent epidemic” that impacts millions. However, strategies to end the deadly effects of viral hepatitis don’t stop there. Personalized treatment is another essential tool that fuels better outcomes for patients with hepatitis C (HCV) while…more.